124 related articles for article (PubMed ID: 33464268)
1. Budded baculoviruses as a receptor display system to quantify ligand binding with TIRF microscopy.
Laasfeld T; Ehrminger R; Tahk MJ; Veiksina S; Kõlvart KR; Min M; Kopanchuk S; Rinken A
Nanoscale; 2021 Feb; 13(4):2436-2447. PubMed ID: 33464268
[TBL] [Abstract][Full Text] [Related]
2. Live-cell microscopy or fluorescence anisotropy with budded baculoviruses-which way to go with measuring ligand binding to M
Tahk MJ; Torp J; Ali MAS; Fishman D; Parts L; Grätz L; Müller C; Keller M; Veiksina S; Laasfeld T; Rinken A
Open Biol; 2022 Jun; 12(6):220019. PubMed ID: 35674179
[TBL] [Abstract][Full Text] [Related]
3. Budded baculoviruses as a tool for a homogeneous fluorescence anisotropy-based assay of ligand binding to G protein-coupled receptors: the case of melanocortin 4 receptors.
Veiksina S; Kopanchuk S; Rinken A
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):372-81. PubMed ID: 24095674
[TBL] [Abstract][Full Text] [Related]
4. Homogeneous fluorescence anisotropy-based assay for characterization of ligand binding dynamics to GPCRs in budded baculoviruses: the case of Cy3B-NDP-α-MSH binding to MC4 receptors.
Veiksina S; Kopanchuk S; Mazina O; Link R; Lille A; Rinken A
Methods Mol Biol; 2015; 1272():37-50. PubMed ID: 25563175
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence Anisotropy-Based Assay for Characterization of Ligand Binding Dynamics to GPCRs: The Case of Cy3B-Labeled Ligands Binding to MC
Veiksina S; Tahk MJ; Laasfeld T; Link R; Kopanchuk S; Rinken A
Methods Mol Biol; 2021; 2268():119-136. PubMed ID: 34085265
[TBL] [Abstract][Full Text] [Related]
6. Implementation of fluorescence anisotropy-based assay for the characterization of ligand binding to dopamine D
Allikalt A; Kopanchuk S; Rinken A
Eur J Pharmacol; 2018 Nov; 839():40-46. PubMed ID: 30205112
[TBL] [Abstract][Full Text] [Related]
7. Characterization of 5-HT₁A receptors and their complexes with G-proteins in budded baculovirus particles using fluorescence anisotropy of Bodipy-FL-NAN-190.
Tõntson L; Kopanchuk S; Rinken A
Neurochem Int; 2014 Feb; 67():32-8. PubMed ID: 24508405
[TBL] [Abstract][Full Text] [Related]
8. Assays with Detection of Fluorescence Anisotropy: Challenges and Possibilities for Characterizing Ligand Binding to GPCRs.
Rinken A; Lavogina D; Kopanchuk S
Trends Pharmacol Sci; 2018 Feb; 39(2):187-199. PubMed ID: 29102621
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence based HTS-compatible ligand binding assays for dopamine D
Tahk MJ; Laasfeld T; Meriste E; Brea J; Loza MI; Majellaro M; Contino M; Sotelo E; Rinken A
Front Mol Biosci; 2023; 10():1119157. PubMed ID: 37006609
[TBL] [Abstract][Full Text] [Related]
10. Structure-Based Design of High-Affinity Fluorescent Probes for the Neuropeptide Y Y
Müller C; Gleixner J; Tahk MJ; Kopanchuk S; Laasfeld T; Weinhart M; Schollmeyer D; Betschart MU; Lüdeke S; Koch P; Rinken A; Keller M
J Med Chem; 2022 Mar; 65(6):4832-4853. PubMed ID: 35263541
[TBL] [Abstract][Full Text] [Related]
11. Budded baculovirus particles as a source of membrane proteins for radioligand binding assay: The case of dopamine D
Allikalt A; Rinken A
J Pharmacol Toxicol Methods; 2017 Jul; 86():81-86. PubMed ID: 28412328
[TBL] [Abstract][Full Text] [Related]
12. A combinatorial G protein-coupled receptor reconstitution system on budded baculovirus. Evidence for Galpha and Galphao coupling to a human leukotriene B4 receptor.
Masuda K; Itoh H; Sakihama T; Akiyama C; Takahashi K; Fukuda R; Yokomizo T; Shimizu T; Kodama T; Hamakubo T
J Biol Chem; 2003 Jul; 278(27):24552-62. PubMed ID: 12721292
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of ligand binding to GPCR: Residence time of melanocortins and its modulation.
Rinken A; Veiksina S; Kopanchuk S
Pharmacol Res; 2016 Nov; 113(Pt B):747-753. PubMed ID: 27268144
[TBL] [Abstract][Full Text] [Related]
14. Baculovirus display for discovery of low-affinity extracellular receptor-ligand interactions using protein microarrays.
Tom I; Estevez A; Bowman K; Gonzalez LC
Anal Biochem; 2015 Jun; 479():1-5. PubMed ID: 25797350
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ligand binding to melanocortin 4 receptors using fluorescent peptides with improved kinetic properties.
Link R; Veiksina S; Rinken A; Kopanchuk S
Eur J Pharmacol; 2017 Mar; 799():58-66. PubMed ID: 28132916
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of ligand binding modes at the neuropeptide Y Y
Yang Z; Han S; Keller M; Kaiser A; Bender BJ; Bosse M; Burkert K; Kögler LM; Wifling D; Bernhardt G; Plank N; Littmann T; Schmidt P; Yi C; Li B; Ye S; Zhang R; Xu B; Larhammar D; Stevens RC; Huster D; Meiler J; Zhao Q; Beck-Sickinger AG; Buschauer A; Wu B
Nature; 2018 Apr; 556(7702):520-524. PubMed ID: 29670288
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
Cabrele C; Beck-Sickinger AG
J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209
[TBL] [Abstract][Full Text] [Related]
18. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology.
Mellentin-Michelotti J; Evangelista LT; Swartzman EE; Miraglia SJ; Werner WE; Yuan PM
Anal Biochem; 1999 Aug; 272(2):182-90. PubMed ID: 10415087
[TBL] [Abstract][Full Text] [Related]
19. Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors.
Keller M; Kaske M; Holzammer T; Bernhardt G; Buschauer A
Bioorg Med Chem; 2013 Nov; 21(21):6303-22. PubMed ID: 24074877
[TBL] [Abstract][Full Text] [Related]
20. Novel analogues of neuropeptide Y with a preference for the Y1-receptor.
Söll RM; Dinger MC; Lundell I; Larhammer D; Beck-Sickinger AG
Eur J Biochem; 2001 May; 268(10):2828-37. PubMed ID: 11358498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
